115 related articles for article (PubMed ID: 9580146)
1. Lack of response of thrombocytopenia associated with human immunodeficiency virus to triple antiretroviral therapy.
Domingo P; Coma E; Muñiz-Díaz E
Arch Intern Med; 1997 Dec 8-22; 157(22):2669-70. PubMed ID: 9580146
[No Abstract] [Full Text] [Related]
2. Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection.
Arranz Caso JA; Sanchez Mingo C; Garcia Tena J
N Engl J Med; 1999 Oct; 341(16):1239-40. PubMed ID: 10523161
[No Abstract] [Full Text] [Related]
3. Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors.
Carbonara S; Fiorentino G; Serio G; Maggi P; Ingravallo G; Monno L; Bruno F; Coppola S; Pastore G; Angarano G
J Infect; 2001 May; 42(4):251-6. PubMed ID: 11545567
[TBL] [Abstract][Full Text] [Related]
4. Response of HIV-associated thrombocytopenia to triple agent antiretroviral therapy.
Walsh JC; Costello CE; Nelson MR
AIDS; 1997 Mar; 11(3):399-400. PubMed ID: 9147442
[No Abstract] [Full Text] [Related]
5. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
[TBL] [Abstract][Full Text] [Related]
7. Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison.
Scaradavou A; Cunningham-Rundles S; Ho JL; Folman C; Doo H; Bussel JB
Am J Hematol; 2007 May; 82(5):335-41. PubMed ID: 17154377
[TBL] [Abstract][Full Text] [Related]
8. Viral load and combination therapy for human immunodeficiency virus.
Phillips AN; Smith GD
N Engl J Med; 1997 Mar; 336(13):958-9; author reply 960. PubMed ID: 9072697
[No Abstract] [Full Text] [Related]
9. [Severe thrombocytopenia and human immunodeficiency virus infection. Report of two cases and review].
Pizarro P R; Aguad R L; Castro G JL
Rev Chilena Infectol; 2007 Feb; 24(1):63-7. PubMed ID: 17369974
[TBL] [Abstract][Full Text] [Related]
10. Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine.
Bocket L; Yazdanpanah Y; Ajana F; Gerard Y; Viget N; Goffard A; Alcaraz I; Wattré P; Mouton Y
J Antimicrob Chemother; 2004 Jan; 53(1):89-94. PubMed ID: 14645320
[TBL] [Abstract][Full Text] [Related]
11. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
Clark NM; Dieng Sarr A; Sankalé JL; Kanki PJ; Kazanjian P; Winfield R; Markovitz DM
AIDS; 1998 Dec; 12(18):2506-7. PubMed ID: 9875594
[No Abstract] [Full Text] [Related]
12. Recurring thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection.
Ananworanich J; Phanuphak N; Nuesch R; Apateerapong W; Rojnuckarin P; Ubolyam S; Phanuphak P; Ruxrungtham K
Clin Infect Dis; 2003 Sep; 37(5):723-5. PubMed ID: 12942407
[TBL] [Abstract][Full Text] [Related]
13. Adipose redistribution in human immunodeficiency virus-seropositive patients: association with CD4 response.
Wurtz R; Ceaser S
Clin Infect Dis; 2000 Dec; 31(6):1497-8. PubMed ID: 11096021
[TBL] [Abstract][Full Text] [Related]
14. Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
Mocroft A; Phillips AN; Ledergerber B; Katlama C; Chiesi A; Goebel FD; Knysz B; Antunes F; Reiss P; Lundgren JD
AIDS; 2006 May; 20(8):1141-50. PubMed ID: 16691065
[TBL] [Abstract][Full Text] [Related]
15. Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings?
Bagchi S; Kempf MC; Westfall AO; Maherya A; Willig J; Saag MS
Clin Infect Dis; 2007 Jan; 44(1):135-8. PubMed ID: 17143829
[TBL] [Abstract][Full Text] [Related]
16. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients.
Rodriguez B; Woolley I; Lederman MM; Zdunek D; Hess G; Valdez H
J Infect Dis; 2003 Feb; 187(3):504-7. PubMed ID: 12552436
[TBL] [Abstract][Full Text] [Related]
17. Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience.
Rajasekaran S; Jeyaseelan L; Vijila S; Gomathi C; Raja K
AIDS; 2007 Jul; 21 Suppl 4():S47-53. PubMed ID: 17620752
[TBL] [Abstract][Full Text] [Related]
18. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
[TBL] [Abstract][Full Text] [Related]
19. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
García F; Vidal C; Plana M; Cruceta A; Gallart MT; Pumarola T; Miro JM; Gatell JM
Clin Infect Dis; 2000 Feb; 30(2):392-4. PubMed ID: 10671348
[TBL] [Abstract][Full Text] [Related]
20. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
